Literature DB >> 35001081

Psychosocial outcomes of parents in pediatric haploidentical transplant: parental hematopoietic cell donation as a double-edged sword.

Vanessa Aguilera1, Megan R Schaefer1, Kendra Parris1, Alanna Long1, Brandon Triplett2, Sean Phipps3.   

Abstract

Parents are increasingly used as donors for their child's haploidentical hematopoietic cell transplant, creating a dual role for parents that may increase the stress of caring for their ill child. Empiric research on the psychological adjustment of parental donors is lacking. We conducted a retrospective survey of parents (n = 136) whose child underwent transplant with a parental donor or a matched-unrelated donor, including both donor and nondonors, and both parents of survivors and bereaved. All parents completed standardized measures of quality of life, depression, anxiety, post-traumatic stress, and life satisfaction. Bereaved parents also completed measures of their grief response, while parents of survivors completed measures of the parent-child relationship. The overall sample reported psychological functioning near normative levels, but bereaved parents demonstrated significantly poorer outcomes across all measures. The effect of donor status differed by transplant outcome: for parents of survivors, donors reported better mental health than nondonors, but amongst bereaved parents, donors fared more poorly than nondonors. Bereaved donors reported greater difficulties with grief than nondonors. Results suggest that serving as donor can be a double-edged sword, acting as a protective factor when there is a successful outcome but a significant risk factor when the child does not survive.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 35001081      PMCID: PMC9455732          DOI: 10.1038/s41409-021-01547-9

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.174


  33 in total

Review 1.  Psychological effects of hematopoietic SCT on pediatric patients, siblings and parents: a review.

Authors:  W Packman; S Weber; J Wallace; N Bugescu
Journal:  Bone Marrow Transplant       Date:  2010-04-12       Impact factor: 5.483

Review 2.  Recent progress in haploidentical transplantation: is this the optimal choice for alternative donor transplantation?

Authors:  Mizuki Watanabe; Junya Kanda
Journal:  Curr Opin Hematol       Date:  2019-11       Impact factor: 3.284

3.  Trajectories of child and caregiver psychological adjustment in families of children with cancer.

Authors:  Lynn Fainsilber Katz; Kaitlyn Fladeboe; Kevin King; Kyrill Gurtovenko; Joy Kawamura; Debra Friedman; Bruce Compas; Meredith Gruhn; David Breiger; Liliana Lengua; Iris Lavi; Nicole Stettler
Journal:  Health Psychol       Date:  2018-08       Impact factor: 4.267

4.  Differences in mothers' and fathers' psychological distress after pediatric SCT: a longitudinal study.

Authors:  M Barrera; E Atenafu; J Doyle; D Berlin-Romalis; K Hancock
Journal:  Bone Marrow Transplant       Date:  2011-10-31       Impact factor: 5.483

5.  Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.

Authors:  Franco Locatelli; Pietro Merli; Daria Pagliara; Giuseppina Li Pira; Michela Falco; Daniela Pende; Roberto Rondelli; Barbarella Lucarelli; Letizia Pomponia Brescia; Riccardo Masetti; Giuseppe Maria Milano; Valentina Bertaina; Mattia Algeri; Rita Maria Pinto; Luisa Strocchio; Raffaella Meazza; Lavinia Grapulin; Rupert Handgretinger; Alessandro Moretta; Alice Bertaina; Lorenzo Moretta
Journal:  Blood       Date:  2017-06-06       Impact factor: 22.113

6.  Adjustment in parents of children undergoing stem cell transplantation.

Authors:  Jennifer J Lindwall; Kathy Russell; Qinlei Huang; Hui Zhang; Kathryn Vannatta; Maru Barrera; Melissa Alderfer; Sean Phipps
Journal:  Biol Blood Marrow Transplant       Date:  2014-01-13       Impact factor: 5.742

7.  The impact of childhood cancer on the family: a qualitative analysis of strains, resources, and coping behaviors.

Authors:  Joän M Patterson; Kristen E Holm; James G Gurney
Journal:  Psychooncology       Date:  2004-06       Impact factor: 3.894

8.  Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution.

Authors:  Ewelina Mamcarz; Renee Madden; Amr Qudeimat; Ashok Srinivasan; Aimee Talleur; Akshay Sharma; Ali Suliman; Gabriela Maron; Anusha Sunkara; Guolian Kang; Wing Leung; Stephen Gottschalk; Brandon M Triplett
Journal:  Bone Marrow Transplant       Date:  2019-11-18       Impact factor: 5.483

9.  Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults.

Authors:  Heather J Symons; Marianna Zahurak; Yilin Cao; Allen Chen; Kenneth Cooke; Christopher Gamper; Orly Klein; Nicolas Llosa; Elias T Zambidis; Richard Ambinder; Javier Bolaños-Meade; Ivan Borrello; Robert Brodsky; Amy DeZern; Ivana Gojo; Margaret Showel; Lode Swinnen; B Douglas Smith; Leo Luznik; Richard J Jones; Ephraim J Fuchs
Journal:  Blood Adv       Date:  2020-08-25

10.  Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; R F Duarte; C Dufour; A Gennery; N Kröger; J Kuball; F Lanza; S Montoto; A Nagler; J A Snowden; J Styczynski; M Mohty
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.